Real-world data as an evidence source in nuclear medicine

Real-world data as an evidence source in nuclear medicine

  • RWE use is becoming particularly relevant in oncology, as only a small percentage of adult cancer patients worldwide are enrolled in clinical trials whereas the number of therapeutic options and the segmentation of patient populations are rapidly increasing, leading to the explosive growth of research questions and evidence gaps
  • High-quality RWE from electronic health records (EHRs) is increasingly recognised as an opportunity to fill evidence gaps, especially for applications for which prospective clinical studies are infeasible or when the potential benefit of the diagnostic or therapeutic intervention is large
  • Nuclear medicine technology, in both diagnostics and therapeutics, represents a remaining frontier that could benefit from new insights derived from RWE
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at